In this episode, host Prof. Jan Gutermuth explores with Prof. Christoffer Gebhardt the evolving landscape of melanoma prognosis.
Together they discuss current strategies for predicting outcomes in melanoma patients, including clinical staging, histopathological features, and emerging molecular and genetic biomarkers. The conversation highlights how personalised medicine and novel diagnostic tools are shaping prognosis accuracy and guiding treatment decisions.
Ideal for dermatologists, oncologists, and researchers, this #EADVPodcast episode underscores the importance of integrating science and patient care to improve long-term survival in melanoma.
Passionate about Personalised Medicine? JEADV has an ongoing Call for Papers waiting for your contribution. Visit our website to know more: JEADV Call for papers: Personalised Medicine in Dermatology
Link to video version: https://www.youtube.com/playlist?list=PL2DbuyADMP5mFx4sZqS_vQtdTGOGIbwb1
You are invited to participate in our survey to improve the show. Your feedback is valued and appreciated to allow us to better serve our audience: https://eadv.org/eadv-podcast-survey/